Neuroinflammatory / neuropsychiatric disorder

Clinical trials for Neuroinflammatory / neuropsychiatric disorder explained in plain language.

Never miss a new study

Get alerted when new Neuroinflammatory / neuropsychiatric disorder trials appear

Sign up with your email to follow new studies for Neuroinflammatory / neuropsychiatric disorder, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can an immune-targeting antibody reverse sudden losses in down syndrome?

Disease control Not yet recruiting

Down syndrome regression disorder (DSRD) causes a sudden loss of thinking, language, or daily skills in some people with Down syndrome. Researchers are testing ublituximab, an antibody that targets immune cells, in 20 adults aged 18 to 40 who have DSRD and did not respond well en…

Matched conditions: NEUROINFLAMMATORY / NEUROPSYCHIATRIC DISORDER

Phase 2 • Sponsor: Jonathan Santoro • Aim: Disease control

Last updated Sep 12, 2026 00:00 UTC

Neuroinflammatory / neuropsychiatric disorder

Get alerted when new Neuroinflammatory / neuropsychiatric disorder trials appear

Can an immune-targeting antibody reverse sudden losses in down syndrome?